NCT02824679View on ClinicalTrials.gov

Effect of Intravenous Hyoscine Butylbromide Injection on First Stage Labour in Primigavidae

PHASE4CompletedINTERVENTIONAL
Enrollment

200

Participants

Timeline

Start Date

July 31, 2015

Primary Completion Date

December 31, 2016

Study Completion Date

March 31, 2017

Conditions
Vaginal Delivery
Interventions
DRUG

hyoscine butylbromide

20 - 40 mg of hyoscine butylbromide is given intravenously during the first stage of labor

DRUG

saline

0.9%normal saline

All Listed Sponsors
lead

Ahmed M Maged, MD

OTHER

NCT02824679 - Effect of Intravenous Hyoscine Butylbromide Injection on First Stage Labour in Primigavidae | Biotech Hunter | Biotech Hunter